Evidence map›Paper›PMID 42397449›Full record

ArticleInternational journal of colorectal disease2026

Long-term disease-free survival in young-onset rectal cancer patients surgically treated with curative intent: a retrospective cohort study.

Oddne Fjellstad Johnsen, Rolf Nerem Riis, Sebastian Meltzer, Anne Hansen Ree, Knut Magne Augestad

Abstract read
In one paragraph

Article in International journal of colorectal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oddne Fjellstad Johnsen *Department of Gastrointestinal Surgery, Akershus University Hospital, Oslo, Norway. Oddne.Fjellstad.Johnsen@ahus.no.ORCID https://orcid.org/0009-0007-3431-8569
Rolf Nerem Riis *Department of Gastrointestinal Surgery, Akershus University Hospital, Oslo, Norway.
Sebastian MeltzerDepartment of Oncology, Akershus University Hospital, Oslo, Norway.
Anne Hansen ReeDepartment of Oncology, Akershus University Hospital, Oslo, Norway.
Knut Magne AugestadDepartment of Gastrointestinal Surgery, Akershus University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough colorectal cancer incidence is declining among individuals aged over 50 years, possibly due to screening, young-onset rectal cancer (YORC) in those under 50 years of age is increasing. YORC is often diagnosed at advanced stages, leading to worse outcomes and higher mortality. This study compared short- and long-term clinical, surgical, and pathological outcomes, including survival, between patients with YORC (< 50 years) and older age groups.

methodA retrospective single-center study of patients undergoing curative-intent resection for rectal cancer at a Norwegian university hospital from 2014 to 2024. We divided the cohort into three age groups: < 50 (YORC), 50-75, and > 75. Clinical and pathological parameters, surgical complications, and overall and disease-free survival (DFS) were compared using parametric and nonparametric analyses, Kaplan-Meier methods, and Cox proportional hazard regression.

results642 patients underwent curative-intent surgery for rectal cancer: YORC: n = 53 (8%); 50-75: n = 435 (68%); and > 75: n = 154 (24%). The mean age for YORC was 44 years (range 26-49). The median follow-up was 52.4 months, with an interquartile range (IQR) of 27.9-85.6 months. The oldest age group had worse DFS during follow-up (p < 0.0001, log-rank test); YORC 7 events (13.5%); 50-75 67 events (16.1%); and > 75 66 (44.9%). DFS was comparable between the YORC and the 50-75 group (p = 0.6, log-rank test). Cox models showed poorer DFS in patients aged > 75 (hazard ratio 3.04, p = 0.009) and in those with higher American Society of Anesthesiologists scores or higher pathological stages.

conclusionThe YORC group had DFS outcomes comparable to those of patients aged 50-75 following curative-intent surgery. WHAT DOES THIS PAPER ADD TO THE LITERATURE?: While the incidence of YORC has increased over the past decades, few studies have analyzed survival beyond five years. This study compares YORC patients who were followed for a median of more than five years with groups of older patients with shorter follow-up (56.0 months for those aged 50-75 years, and 39.7 for those aged > 75). The outcomes for YORC patients, including disease-free survival, were comparable to those aged 50-75.

Indexed as

Rectal NeoplasmsAdultAgedAge of OnsetColorectal Surgical ProceduresDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMiddle AgedRetrospective StudiesCancer-free survivalDisease-free survivalEarly-onsetOutcomesRectal cancerYoung-onset

Identifiers

PMID42397449
PMCPMC13601128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.